GSK-3: A key player in neurodegeneration and memory

IUBMB Life

Volumn 61, Issue 5, 2009, Pages 516-521

  Giese, Karl Peter ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Kinase; Memory; Molecular signaling; Neurodegeneration

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3; TAU PROTEIN;

ALZHEIMER DISEASE; ENZYME ACTIVITY; HIPPOCAMPUS; HISTOPATHOLOGY; MEMORY; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; DEGENERATIVE DISEASE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

MUS; RODENTIA;

GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MEMORY; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; PHOSPHORYLATION; TAU PROTEINS;

EID: 67650376160     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.187     Document Type: Review

References (62)

1. Embi, N., Rylatt, D. B., and Cohen, P. (1980) Glycogen synthase kinase 3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107, 519-527.
2. Woodgett, J. R. (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9, 2431-2438.
3. Yao, H. B., Shaw, P. C., Wong, C. C., and Wan, D. C. (2002) Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain. J. Chem. Neuroanat. 23, 291-297.
4. Plattner, F., Angelo, M., and Giese, K. P. (2005) The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J. Biol. Chem. 281, 25457-25465.
5. Lee, S. J., Chung, Y. H., Jooa, K. M., Lima, H. C., Jeona, G. S., Kimb, D., Leeb, W. B., Kimc, Y. S., and Cha, C. I. (2006) Age-related changes in glycogen synthase kinase 3β (GSK3β) immunoreactivity in the central nervous system of rats. Neurosci. Lett. 409, 134-139.
6. Cohen, P. and Frame, S. (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell. Biol. 2, 769-776.
7. Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C., and Pearl, L. H. (2001) Crystal structure of glyogen synthase kinase 3 beta: structural basis for phosphate-primed substrate and autoinhibition. Cell 105, 721-732.
8. Doble, B. W. and Woodgett, J. R. (2003) GSK-3: tricks of the trade for a multi-task kinase. J. Cell Sci. 116, 1175-1186.
9. Peineau, S., Taghibiglou, C., Bradley, C., Wong, T. P., Liu, L., Lu, J., Lo, E., Wu, D., Saule, E., Bouschet, T., Matthews, P., Isaac, J. T., Bortolotto, Z. A., Wang, Y. T., and Collingridge, G. L. (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53, 703-717.
10. McManus, E. J., Sakamoto, K., Armit, L. J., Ronaldson, L., Shpiro, N., Marquez, R., and Alessi, D. R. (2005). Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J. 24, 1571-1583.
11. Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B., and Rincon, M. (2008) Phosphorylation by p38 MAPK as an alternative pathway for GSK3β inactivation. Science 320, 667-670.
12. Bhat, R. V., Shanley, J., Correll, M. P., Fieles, W. E., Keith, R. A., Scott, C. W., and Lee, C.-M. (2000) Regulation and localization of tyrosine 216 phosphorylation of glycogen synthase kinase-3b in cellular and animal models of neuronal neurodegneration. Proc. Natl. Acad. Sci. (USA) 97, 11074-11079.
13. Goni-Oliver, P., Lucas, J. J., Avila, J., and Hernandez, F. (2007) N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation. J. Biol. Chem. 282, 22406-22413.
14. Ferrer, I., Barrachina, M., and Puig, B. (2002) Glycogen synthase kinase- 3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 104, 583-591.
15. Yamagauchi, H., Ishiguro, K., Uchida, T., Takashima, A., Lemere, C. A., and Imahori, K. (1996) Preferential labelling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glcogen synthase kinase-3 beat and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol. 92, 232-241.
16. Pei, J. J., Tanaka, T., Tung, Y. C., Braak, E., Iqbal, K., and Grundke-Iqbal, I. (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J. Neuropathol. Exp. Neurol. 56, 70-78.
17. Pei, J. J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., and Cowburn, R. F. (1999) Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer's disease neurofibrillary changes. J. Neuropathol. Exp. Neurol. 58, 1010-1019.
18. Leroy, K, Boutajangout, A., Authelet, M., Woodgett, J. R., Anderton, B. H., and Brion, J. P. (2002) The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Acta Neuropathol. 103, 91-99.
19. Leroy, K., Yilmmaz, Z., and Brion, J. P. (2007) Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurons at different stages of neurofibrillary degernation. Neuropathol. Appl. Neurobiol. 33, 43-55.
20. Selkoe, D. J. (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791.
21. Takashima, A. (2006) GSK-3 is essential in the pathogenesis of Alzheimer's disease. J. Alzheimer's Dis. 9, 309-317.
22. Hooper, C., Markevich, V., Plattner, F., Killick, R., Schofield, E., Engel, T., Hernandez, F., Anderton, B., Rosenblum, K., Cooke, S. F., Avila, J., Lucas, J. J., Giese, K. P., Stepenson, J., and Lovestone, S. (2007) Glycogen synthase kinase-3 inhibition is integral to long-term potentation. Eur. J. Neurosci. 25, 81-86.
23. Pocklington, A. J., Cumiskey, M., Armstrong, J. D., and Grant, S. G. (2006) The proteomes of neurotransmitter receptor complexes form modular networks with distributed functionality underlying plasticity and behaviour. Mol. Syst. Biol. 2, 0023.
24. Zhu, L.-Q., Wang, S.-H., Liu, D., Yin, Y.-Y., Tian, Q., Wang, X.-C., Wang, Q., Chen, J.-G., and Wang, J.-Z. (2007) Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments. J. Neurosci. 27, 12211-12220.
25. Andersen, P., Morris, R., Amaral, D., Bliss, T., and O'Keefe, J. (2007). The hippocampus Book. Oxford University Press, Oxford, United Kingdom.
26. Peineau, S., Bradley, C., Taghibiglou, C., Doherty, A., Bortolotto, Z. A., Wang, Y. T., and Collingridge, G. L. (2008) The role of GSK-3 in synaptic plasticity. Br. J. Pharmacol. 153, 5428-5437.
27. Hernandez, F., Borrell, J., Guaza, C., Avila, J., and Lucas, J. J. (2002) Spatial learning deficits in transgenic mice that conditionally overexpress GSK-3beta in the brain but do not form tau filaments. J. Neurochem. 83, 1529-1533.
28. Liu, S. J., Zhang, A. H., Li, H. L., Wang, Q., Deng, H. M., Netzer, W. J., Xu, H., and Wang, J. Z. (2003) Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J. Neurochem. 87, 1333-1344.
29. Fujio, J., Hosono, H., Ishiguro, K., Ikegami, S., and Fujita, S. C. (2007) Tau phosphorylation in the mouse brain during aversive conditioning. Neurochem. Int. 51, 200-208.
30. Magauschak, K. A. and Ressler, K. J. (2008) beta-catenin is required for memory consolidation. Nat. Neurosci. 11, 1319-1326.
31. Kimura, T., Yamashita, S., Nakao, S., Park, J. M., Murayama, M., Mizoroki, T., Yoshiike, Y., Sahara, N., and Takashima, A. (2008) GSK-3beta is required for memory reconsolidation in adult brain. PLoS ONE 3, e3540.
32. Lee, J. L. (2008) Memory reconsolidation mediates the strengthening of memories by additional learning. Nat. Neurosci. 11, 1264-1266.
33. Cuchillo-Ibanez, I., Seereeram, A., Byers, H. L., Leung, K.-Y., Ward, M. A., Anderton, B. H., and Hanger, D. P. (2008) Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J. 22, 3186-3195.
34. Santacruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., Forster, C., Yue, M., Orne, J., Janus, C., Mariash, A., Kuskowski, M., Hyman, B., Hutton, M., and Ashe, K. H. (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476-481.
35. Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J. P., and Anderton, B. H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58-62.
36. Mandelkow, E. M., Drewes, G., Biernat, J., Gustke, J., Van Lint, J., Vandenheede, J. R., and Mandelkow, E. (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 314, 315-321.
37. Ishiguro, K., Omori, A., Takamatsu, M., Sato, K., Arioka, M., Uchida, T., and Imahori, K. (1992) Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci. Lett. 148, 202-206.
38. Li, T., Hawkes, C., Qureshi, H. Y., Kar, S., and Paudel, H. K. (2006) Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3 beta. Biochemistry 45, 3134-3145.
39. Brownlees, J., Irving, N. G., Brion, J. P., Gibb, B. J., Wagner, U., Woodgett, J., and Miller, C. C. (1997) Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes. Neuroreport 8, 3251-3255.
40. Lucas, J. J., Hernandez, F., Gomez-Ramos, P., Moran, M. A., Hen, R., and Avila, J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 20, 27-39.
41. Engel, T., Hernandez, F., Avila, J., and Lucas, J. J. (2006) Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. J. Neurosci. 26, 5083-5090.
42. Engel, T., Goni-Oliver, P., Lucas, J. J., Avila, J., and Hernandez, F. (2006) Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. J. Neurochem. 99, 1445-1455.
43. Jackson, G. R., Wiedau-Pazos, M., Sang, T. K., Wagle, N., Brown, C. A., Massachi, S., and Geschwind, D. H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509-519.
44. Giese, K. P., Ris, L., and Plattner, F. (2005) Is there a role of the cyclin-dependent kinase 5 activator p25 in Alzheimer's disease? Neuroreport 16, 1725-1730.
45. Angelo, M., Plattner, F., Irvine, E. E., and Giese, K. P. (2003) Improved reversal learning and altered fear conditioning in transgenic mice with regionally restricted p25 expression. Eur. J. Neurosci. 18, 423-431.
46. Wen, Y., Planel, E., Herman, M., Figueroa, H. Y., Wang, L., Liu, L., Lau, L. F., Yu, W. H., and Duff, K. E. (2008) Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. J. Neurosci. 28, 2624-2632.
47. Wilson, R. J. (2008) Towards a cure for dementia: the role of axonal transport in Alzheimer's disease. Sci. Prog. 91, 65-80.
48. Dixit, R., Ross, J. L., Goldman, Y. E., and Holzbaur, E. L. (2008) Differential regulation of dynein and kinesin motor proteins by tau. Science 319, 1086-1089.
49. Verdile, G., Fuller, S., Atwood, C. S., Laws, S. M., Gandy, S. E., and Martins, R. N. (2005) The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught? Pharmacol. Res. 50, 397-409.
50. Hooper, C., Killick, R., and Lovestone, S. (2008) The GSK3 hypothesis of Alzheimer's disease. J. Neurochem. 104, 1433-1439.
51. Muyllaert, D., Kremer, A., Jaworski, T., Borghgraef, P., Devijver, H., Croes, S., Dewachter, I., and van Leuven, F. (2008) Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology? Genes Brain Behav. 7 (Suppl 1), 57-66.
52. Takashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K., and Imahori, K. (1996) Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neurosci. Lett. 203, 33-36.
53. Terwel, D., Muyllaert, D. Dewachter, I., Borghgraef, P., Croes, S., Devijver, H., and van Leuven, F. (2008) Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am. J. Pathol. 172, 786-798.
54. Phiel, C. J., Wilson, C. A., Lee, V. M., and Klein, P. S. (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423, 435-439.
55. Uemura, K., Kuzuya, A., Shimozono, Y., Aoyagi, N., Ando, K., Shimohama, S., and Kinoshita, A. (2007) GSK3beta activity modifies the localization and function of presenilin 1. J. Biol. Chem. 282, 15823-15832.
56. Rockenstein, E., Torrance, M., Adame, A., Mante, M., Bar-on, P., Rose, J. B., Crews, L., and Masliah, E. (2007) Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. J. Neurosci. 27, 1981-1991.
57. Koh, S. H., Noh, M. Y., and Kim, S. H. (2008) Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3. Brain Res. 1188, 254-262.
58. Cardona-Gomez, P., Perez, M., Avila, J., Garcia-Segura, L. M., and Wandosell, F. (2004) Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus. Mol. Cell Neurosci. 25, 363-373.
59. Czlonkowska, A., Ciesielska, A., Gromadzka, G., and Kurkowska- Jastrzebska, I. (2006) Gender differences in neurological disease: role of estrogens and cytokines. Endocrine 29, 243-256.
60. 2+/calmodulin kinase kinase alpha is dispensable for brain development but is required for distinct memories in male, though not in female, mice. Mol. Cell. Biol. 26, 9094-9104.
61. Mizuno, K., Antunes-Martins, A., Ris, L., Peters, M., Godaux, E., and Giese, K. P. (2007) Calcium/calmodulin kinase kinase beta has a male-specific role in memory formation. Neuroscience 145, 393-402.
62. Antunes-Martins, A., Mizuno, K., Irvine, E. E., Lepicard, E. M., and Giese, K. P. (2007) Sex-dependent up-regulation of two splicing factors, Psf and Srp20, during hippocampal memory formation. Learn. Mem. 14, 693-702.